C. Gegg

发表

An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice

Shuying Liu, N. Chinookoswong, Shu-Chen Lu, 2009, Molecular Pharmacology.

Probing minimal independent folding units in dihydrofolate reductase by molecular dissection

C. Matthews, C. Gegg, K. Bowers, 1997, Protein science : a publication of the Protein Society.

Ligand-Binding Mass Spectrometry to Study Biotransformation of Fusion Protein Drugs and Guide Immunoassay Development: Strategic Approach and Application to Peptibodies Targeting the Thrombopoietin Receptor

C. Gegg, Jean W. Lee, B. Desilva, 2010, The AAPS Journal.

MOL # 52852 14 Chronic Administration of 33 A Had No Effects on Body Weight and Food Intake in DIO Mouse Model

Shuying Liu, N. Chinookoswong, Shu-Chen Lu, 2009 .

Characterization of the adenine binding sites of two Dolichos biflorus lectins.

I. H. Segel, M. Etzler, D. Roberts, 1992, Biochemistry.

Peptide antagonists of the calcitonin gene-related peptide (CGRP) receptor with improved pharmacokinetics and pharmacodynamics.

C. Gegg, B. H. Manning, L. Miranda, 2013, Biopolymers.

Investigation of the effects of altered receptor binding activity on the clearance of erythropoiesis-stimulating proteins: Nonerythropoietin receptor-mediated pathways may play a major role.

K. Aoki, S. Elliott, L. Narhi, 2009, Journal of pharmaceutical sciences.

Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptor.

C. Gegg, L. Miranda, K. Walker, 2008, Journal of medicinal chemistry.

A general approach for the design and isolation of protein fragments: The molecular dissection of dihydrofolate reductase

C. Matthews, C. Gegg, K. Bowers, 1996 .

Interactions between PEG and type I soluble tumor necrosis factor receptor: Modulation by pH and by PEGylation at the N terminus

B. Chang, B. Kerwin, G. Strambini, 2002, Protein science : a publication of the Protein Society.

The inhibition of ribulose 1,5-bisphosphate carboxylase oxygenase by several 2-carboxyhexitol 1- and 6-phosphates

C. Gegg, B. McFadden, T. El-Gul, 2004, Photosynthesis Research.

Molecular modelling of theDolichos biflorus seed lectin and its specific interactions with carbohydrates: α-D-N-acetyl-galactosamine, Forssman disaccharide and blood group A trisaccharide

A. Imberty, M. Etzler, S. Pérez, 1994, Glycoconjugate Journal.

Directional coupling of synthetic peptides to poly-L-lysine and applications to the ELISA.

M. Etzler, C. Gegg, 1993, Analytical biochemistry.

Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.

J. Sullivan, C. Gegg, J. Werner, 2015, Journal of medicinal chemistry.

Mono-N-terminal poly(ethylene glycol)-protein conjugates.

M. Treuheit, C. Gegg, G. Molineux, 2002, Advanced drug delivery reviews.

Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor.

C. Gegg, D. Brankow, N. Kezunovic, 2019, ACS pharmacology & translational science.

Peptibodies: A flexible alternative format to antibodies

Tom Boone, T. Boone, C. Quéva, 2012, mAbs.

Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity.

Katherine A. Winters, L. Poppe, C. Gegg, 2008, Journal of medicinal chemistry.

Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity.

Katherine A. Winters, L. Poppe, C. Gegg, 2008, Journal of medicinal chemistry.

An Acyl-Ghrelin-Specific Neutralizing Antibody Inhibits the Acute Ghrelin-Mediated Orexigenic Effects in Mice

Shuying Liu, N. Chinookoswong, Shu-Chen Lu, 2009, Molecular Pharmacology.